Clinical Microbiology Market Size Worth $16.7 Billion By 2025 | Key Industry participants bioMerieux S.A. And Hoffmann-La Roche Ltd

San Francisco, 22 Nov 2018 - According to a report by Grand View Research, Inc.; the global clinical microbiology market is anticipated to value USD 16.7 billion by 2025. Growing demand for diagnosis of infectious diseases using clinical tests is anticipated to propel market growth over the forecast period (2014 to 2025).

Skilled and technical workforce and their interpretation of clinical specimen results is vital in clinical microbiology. Poor turnaround time (TAT) of clinical tests was one of the major concerns for clinical staff. However, continual technological advancements are replacing various laboratory instruments with automated devices to reduce human error and dependency on skilled workforce. This factor is anticipated to bode well for market growth in near future.

High prevalence of infectious diseases caused by Zika, Ebola, and other such contagious pathogens is predicted to fuel adoption of clinical microbiology. Growing cases of Hospital-Acquired Infections (HAI) is likely to surge demand for microbiology for diagnosis and monitoring. Continual introduction of automated systems and innovative designs is expected to further stimulate market growth during the forecast period.

Access Full Insights On Clinical Microbiology Market: www.grandviewresearch.com/industry-analysis/clinical-microbiology-market

The worldwide clinical microbiology market can be segregated on the basis of product type, application, and region. Based on product type, the market can be categorized into laboratory instruments, microbiology analyzers, and reagents. In 2016, reagents dominated the market and accounted for the largest market share. The segment includes products such as primers, kits, solutions, and master mixes that can be used in various diagnostic assays. It is expected to continue growing at similar pace during the forecast period. Constant repeat purchase and high cost of specialized kits can drive market growth over next few years. In addition, rising demand from analytical and therapeutic research projects can further fuel market growth.

Laboratory instruments include gram strainers, incubators, bacterial colony counters, autoclave sterilizers, petri dish filters, and culture systems. Automated culture systems dominated the global market with 30% share in 2016. Microbiology analyzers comprise instruments used in mass spectrometry, microscope, and molecular diagnostics. Microscopes held the largest market share attributed to rising demand and wider applicability.

Based on application, the market for clinical microbiology can be classified into gastrointestinal diseases, respiratory diseases, Sexually Transmitted Diseases (STDs), Urinary Tract Infections (UTIs), bloodstream infections, periodontal diseases, and others. In 2016, respiratory diseases dominated the market and held the largest market share. Growing level of air pollution attributed to rising industrialization can result in prevalence of respiratory disorders. Such disorders spread rapidly through easy transfer of contagious pathogens. This, in turn, can fuel market growth over next few years.

Regional segmentation includes Europe, North America, Asia Pacific, Latin America, and Middle East and Africa. In 2016, North America accounted for largest market share. Highly developed industrial and healthcare sector in U.S. is expected to surge demand for clinical diagnostic techniques. In addition, tough regulatory framework and presence of leading market players can further fuel regional market expansion. Moreover, continuous rise in research on treatment of infectious diseases and facilitation grants from government healthcare agencies are expected to contribute to regional growth.

Asia Pacific is predicted to grow at a rapid pace from 2016 to 2024. Japan is expected to lead the regional expansion attributed to continual technological advancements and increasing use of microbial testing in various applications. China is estimated to witness significant growth during the forecast period. Availability of advanced manufacturing infrastructure and skilled labor at affordable cost are likely to result in penetration of major pharmaceutical and medical device makers in the region. Moreover, booming medical tourism sector can surge demand for microbial diagnostic and monitoring tests in countries such as Thailand, India, China, and Malaysia.

Some of the leading companies operating in the clinical microbiology market are Abbott Laboratories; Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; Hologic, Inc.; and Becton, Dickinson and Company. Introduction of automated systems and innovative designs are likely to intensify competition and change market dynamics in near future.

Access More Reports Of The Same Category: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global clinical microbiology market on the basis of product, application, and region:

Clinical Microbiology Product Type Outlook (Revenue, USD Million, 2014 - 2025)
  • Laboratory Instruments
    • Incubators
    • Gram Stainers
    • Bacterial Colony Counters
    • Autoclave Sterilizers
    • Petri Dish Fillers
    • Automated Culture Systems
  • Microbiology Analyzers
    • Molecular Diagnostic Instruments
    • Microscopes
    • Mass Spectrometers
  • Reagents
Clinical Microbiology Application Type Outlook (Revenue, USD Million, 2014 - 2025)
  • Respiratory Diseases
  • Bloodstream Infections
  • Gastrointestinal Diseases
  • Sexually Transmitted Diseases
  • Urinary Tract Infections
  • Periodontal Diseases
  • Other Diseases
Clinical Microbiology Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Mexico
    • Brazil
  • Middle East and Africa
    • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

No comments:

Post a Comment

mHealth Apps Market Is Projected To Reach $236.0 Billion By 2026

The global  mHealth apps market  size is expected to reach USD 236.0 billion by 2026, according to a new report by Grand View Research, In...